A New Leu714Arg Variant in the Converter Domain of MYH7 is Associated with a Severe Form of Familial Hypertrophic Cardiomyopathy

• Published in: Frontiers in bioscience (Scholar edition) Vol. 16; no. 1; p. 1
• Main Authors: Golubenko, Maria V, Pavlyukova, Elena N, Salakhov, Ramil R, Makeeva, Oksana A, Puzyrev, Konstantin V, Glotov, Oleg S, Puzyrev, Valery P, Nazarenko, Maria S
• Format: Journal Article
• Language: English
• Published: Singapore IMR Press 23.02.2024
• Subjects: Cardiac Myosins - genetics; Cardiomyopathy, Hypertrophic - genetics; Cardiomyopathy, Hypertrophic, Familial - diagnostic imaging; Cardiomyopathy, Hypertrophic, Familial - genetics; Humans; hypertrophic cardiomyopathy; Mutation; Mutation, Missense - genetics; myh7; myosin converter domain; Myosin Heavy Chains - genetics; Phenotype; myosin converter domain; hypertrophic cardiomyopathy
• ISSN: 1945-0516; 1945-0524
• DOI: 10.31083/j.fbs1601001

Hypertrophic cardiomyopathy is the most frequent autosomal dominant disease, yet due to genetic heterogeneity, incomplete penetrance, and phenotype variability, the prognosis of the disease course in pathogenic variant carriers remains an issue. Identifying common patterns among the effects of different genetic variants is important. We investigated the cause of familial hypertrophic cardiomyopathy (HCM) in a family with two patients suffering from a particularly severe disease. Searching for the genetic variants in HCM genes was performed using different sequencing methods. A new missense variant, p.Leu714Arg, was identified in exon 19 of the beta-myosin heavy chain gene ( ). The mutation was found in a region that encodes the 'converter domain' in the globular myosin head. This domain is essential for the conformational change of myosin during ATP cleavage and contraction cycle. Most reports on different mutations in this region describe severe phenotypic consequences. The two patients with the p.Leu714Arg mutation had heart failure early in life and died from HCM complications. This case presents a new likely pathogenic variant in and supports the hypothesis that myosin converter mutations constitute a subclass of HCM mutations with a poor prognosis for the patient.